ScoreWhy is MedCap AB ?
1
Strong Long Term Fundamental Strength with a 30.65% CAGR growth in Operating Profits
- Company has a low Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 14.67% signifying high profitability per unit of shareholders funds
2
Positive results in Dec 25
- RAW MATERIAL COST(Y) Fallen by -30.92% (YoY)
- CASH AND EQV(HY) Highest at SEK 729.1 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 6.5 times
3
With ROE of 15.26%, it has a very expensive valuation with a 6.21 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 37.94%, its profits have fallen by -3.4%
4
Market Beating Performance
- The stock has generated a return of 37.94% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 10.97%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to MedCap AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is MedCap AB for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
MedCap AB
37.94%
-0.42
37.26%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.86%
EBIT Growth (5y)
30.65%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.31
Tax Ratio
20.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.53%
ROE (avg)
14.67%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
6.21
EV to EBIT
32.36
EV to EBITDA
21.60
EV to Capital Employed
7.31
EV to Sales
4.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.60%
ROE (Latest)
15.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -30.92% (YoY
CASH AND EQV(HY)
Highest at SEK 729.1 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 6.5 times
DEBTORS TURNOVER RATIO(HY)
Highest at 7.16 times
NET SALES(Q)
Highest at SEK 591 MM
OPERATING PROFIT(Q)
Highest at SEK 131.1 MM
OPERATING PROFIT MARGIN(Q)
Highest at 22.18 %
PRE-TAX PROFIT(Q)
Highest at SEK 84.7 MM
NET PROFIT(Q)
Highest at SEK 64.5 MM
EPS(Q)
Highest at SEK 4.31
-10What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 916.78
INTEREST(Q)
Highest at SEK 14.3 MM
Here's what is working for MedCap AB
Net Sales
Highest at SEK 591 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Operating Profit
Highest at SEK 131.1 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Operating Profit Margin
Highest at 22.18 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at SEK 84.7 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Pre-Tax Profit
At SEK 84.7 MM has Grown at 58.02%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK 64.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Net Profit
At SEK 64.5 MM has Grown at 53.04%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK 4.31
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Cash and Eqv
Highest at SEK 729.1 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 6.5 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 7.16 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -30.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at SEK 51.4 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SEK MM)
Depreciation
At SEK 51.4 MM has Grown at 45.2%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (SEK MM)
Here's what is not working for MedCap AB
Interest
At SEK 14.3 MM has Grown at 88.16%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Interest Coverage Ratio
Lowest at 916.78
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at SEK 14.3 MM
in the last five periods and Increased by 88.16% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Non Operating Income
Highest at SEK 0.23 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
